Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model.
Do TND, Abdelnabi R, Boda B, Constant S, Neyts J, Jochmans D. Do TND, et al. Among authors: boda b. bioRxiv [Preprint]. 2024 May 15:2024.05.14.594200. doi: 10.1101/2024.05.14.594200. bioRxiv. 2024. Update in: Antiviral Res. 2024 Nov;231:105994. doi: 10.1016/j.antiviral.2024.105994 PMID: 38798406 Free PMC article. Updated. Preprint.
Establishment of a human nasal epithelium model of histamine-induced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit.
Barbot A, Lheritier-Barrand M, Murrieta-Aguttes M, Leonetti M, Vernaz J, Huang S, Constant S, Boda B. Barbot A, et al. Among authors: boda b. Front Pharmacol. 2024 Jun 12;15:1393702. doi: 10.3389/fphar.2024.1393702. eCollection 2024. Front Pharmacol. 2024. PMID: 38933682 Free PMC article.
The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model.
Do TND, Abdelnabi R, Boda B, Constant S, Neyts J, Jochmans D. Do TND, et al. Among authors: boda b. Antiviral Res. 2024 Nov;231:105994. doi: 10.1016/j.antiviral.2024.105994. Epub 2024 Sep 3. Antiviral Res. 2024. PMID: 39237005 Free PMC article.
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro.
Jonsdottir HR, Siegrist D, Julien T, Padey B, Bouveret M, Terrier O, Pizzorno A, Huang S, Samby K, Wells TNC, Boda B, Rosa-Calatrava M, Engler OB, Constant S. Jonsdottir HR, et al. Among authors: boda b. Biomed Pharmacother. 2022 Jun;150:113058. doi: 10.1016/j.biopha.2022.113058. Epub 2022 May 2. Biomed Pharmacother. 2022. PMID: 35658229 Free PMC article.
38 results